FEATURED COMPANY

MUSCLE FLEX INCORPORATED (OTC: MFLI)

Detailed Quote: http://www.otcpicks.com/quotes/MFLI.php

Company Profile: http://www.otcpicks.com/muscle-flex-inc.htm

Muscle Flex Inc. brings new products to market using direct response TV infomercials specializing in the health, fitness, wellness and hygiene sectors. As well, Muscle Flex Inc. develops and creates general television content for network and cable television distribution. Muscle Flex's corporate strategy is to develop new and innovative products for sale and distribution via its proprietary direct response marketing system and the creation of television media and shows for general network and cable broadcast.

MFLI News:

February 5 - Muscle Flex Announces Conference Call Details

Topics Include The Complete Package Reality TV Show, Alignment with Muscle Flex VATA, Muscle Flex "In the Raw" vs WWE "Raw" Trademark, Sugar Free Daytime Primetime Show and Additional Corporate Updates

Muscle Flex, Inc. (OTC: MFLI) announced that it will be conducting an investor conference call on February 10, 2010 with CEO Danny Alex at 3:00 PM PST. Investor call in information is as follows:

Phone: 712-432-0075
Access Number: 432665

Topics to be discussed include The Complete Package Reality TV Show (“In Search of Miss Muscle Flex”), Kim Kardashian Alignment with Muscle Flex VATA, Muscle Flex “In the Raw” vs. WWE “Raw” Trademark Dispute, Sugar Free Daytime Primetime Show, the short and long term macro corporate strategy, The BUDDY and Beagle Commercials as well as a number of other relevant items related to growth and operational strategies for Muscle Flex Inc.

“Muscle Flex is a company that is developing very quickly and with so much going on in such a short span of time, it is important to provide investors with information on how all of these moving components fit together and specifically how it relates to the revenue growth model of the company,” commented Danny Alex, Muscle Flex’s CEO. “It is important that investors understand our growth strategy through credible and real information and not presumptive speculation as our projects have ‘high profile’ elements associated with them.”

Additional topics to be discussed include the company’s cost structure, revenue models, its partners TLK Fusion and Wesley Morris Entertainment, financing activities and other operational considerations.

Investors are invited to submit their questions to This email address is being protected from spam bots, you need Javascript enabled to view it . Please ensure all emails are short and to the point as long and lengthy emails cannot be attended to.

February 4 - CEO Danny Alex Makes an Investment of $110,000.00 into Muscle Flex for Restricted Stock at $0.03

Muscle Flex Inc. (OTC: MFLI) announced that its CEO, Danny Alex, has made an additional investment of $110,000.00 into Muscle Flex Inc. by way of a direct investment for restricted stock at a share price of $0.03. This sizeable placement follows a number of previous investments Danny Alex has made into the company. The company shall issue 3,666,666 shares of restricted stock to Danny Alex for the $110,000.00 investment.

“I think Muscle Flex has an incredible future and I am happy that I can participate in providing the company with additional capital to grow,” commented Danny Alex. “I regard this investment into Muscle Flex Inc. at a share price of $0.03 as very compelling given the opportunities ahead for the company. At a price of $0.03 I feel I am receiving great value from the company and have always maintained that my commitment is firmly behind the company and its shareholders.”

Muscle Flex is currently working on a number of projects including the recently announced reality show, "The Complete Package." A reality television show that merges Victoria’s Secret style and attitude with "The Apprentice" business savvy has finally arrived! "The Complete Package" was created by Danny Alex, CEO of Muscle Flex, Inc., and is being produced with its partners TLK Fusion and Wesley Morris Entertainment. The chosen winner of the show will be named the season’s official Miss Muscle Flex representative.

Also announced was an open casting call for the pilot episode Saturday, February 27, at 8:00am at HD Vision Broadcast Center in Studio City, California.

"The Complete Package" welcomes all women with a pulse to participate in its edgy, just-when-you-thought-you-had-seen-it-all competition.

February 3 - Muscle Flex Officially Presents 'The Complete Package,' the Reality Television Show in Search of Miss Muscle Flex — With Partners TLK Fusion and Wesley Morris Entertainment

Open Call Casting for Pilot Filming Saturday, February 27, 8:00 a.m.

Muscle Flex Inc. (OTC: MFLI) (www.MuscleFlex.com) announces The Complete Package, a new reality television show that merges Victoria’s Secret style and attitude with The Apprentice business savvy, has finally arrived! Following many hours of deliberation in the boardroom, a title for the competition show has been reached… “The Complete Package,” as created by Danny Alex, CEO of Muscle Flex, Inc., the health, fitness and lifestyle company best recognized for its exclusively female, sassy VATA Sports Collection (www.MuscleFlexVATA.com). The chosen winner of the show will be named the season’s official Miss Muscle Flex representative.

An open casting call for the pilot episode will take place Saturday, February 27, at 8:00am at HD Vision Broadcast Center in Studio City, California.

“The Complete Package” welcomes all women with a pulse to participate in its edgy, just-when-you-thought-you-had-seen-it-all competition.

Thousands of women in all shapes and sizes are expected to participate for a chance at winning the title. The winner will be selected on the following criteria: Beauty, Business Smarts, Fitness, Fashion Sense, Intellect, Sex Appeal, Confidence, Spirit and Heart. The judging line-up will feature Danny Alex with his fellow celebrity judges.

Danny Alex states: “Who is ‘The Complete Package’? This show will redefine what sexy is in America… and we are looking for all of it!”

“The Complete Package” is searching for the new face and image of Muscle Flex for one season. What will the winning contestant receive? The whole Hollywood experience! A contract representing Muscle Flex in advertising, red carpets and other public appearances, photo shoots, special promotions, corporate events as well as giving their smarts in the boardroom.

The 10-episode series will incorporate all of the drama, humor and the unexpected that comes when women compete. How does a beautiful woman get prepared for the opportunity of a lifetime? What decisions go into make-up, hair, wardrobe, and attitude to standout from the rest? What interaction takes place when they’re living with the competition? Who’s their friend and who’s their enemy?

This is a 24/7 competition never out of the eye of the camera. Special features in the show will include fashion couture on-a-budget, a swimsuit contest, perseverance, endurance, fitness, sales and business acumen, public appearances, and getting real in the ‘must see and hear’ Truth Booth. Each week one contestant will be eliminated until only one winner stands in the spotlight.

The audience will also get to follow Danny’s day-to-day business operations, the building of his brand and the interaction between his Muscle Flex staff and the contestants in a Beverly Hills, 90210 setting.

And that's just season one! Which contestant will demonstrate the best staying power? Stay tuned!

“The Complete Package” is co-executive produced by Bill Garnet and Jacque Lueth (both with Wesley Morris Entertainment, Inc., responsible for such shows as “Battle of the Network Stars,” “The Superstars”). Also joining the team as co-executive producers are Alex and his marketing partners, Ken Collis and Tracy Keyser of TLK Fusion Entertainment, Inc.

In a joint statement from the co-executive production team, "We are extremely excited about producing a show that empowers women. Our goal for ‘The Complete Package’ is to bring an edge with a taste of style to reality television."

FEATURED COMPANY

XCELPLUS GLOBAL HOLDINGS INCORPORATED (OTC: XPGH)
"Up 5.71% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/XPGH.php

Company Profile: http://www.otcpicks.com/xcelplus-global-holdings.htm

Xcelplus Global Holdings, Inc., a development stage company, develops and produces federally compliant biomass based renewable fuels for the light, medium, and heavy industries. Its product lines include synthetic fuel oils, biomass release agent, and btu enhancer. The company holds various technologies and licenses them for manufacturing and distribution. Its technologies include digiflex, lubrilon, alternative energy centers, E85 flex lube centers, diesenol, glycoal, and glyclene. The company is headquartered in Dothan, Alabama.

XPGH News:

February 4 - XcelPlus Global Holdings Sees Bright Future in Revisions to Renewable Fuel Standard Program

XcelPlus Global Holdings, Inc. (OTC: XPGH), a leading manufacturer and distributor of industrial biofuels, gained a solid foothold on its future growth and stability this week with the passing of revisions to the National Renewable Fuel Standard (RFS2) program by the Environmental Protection Agency (EPA). The revised statutory requirements establish new annual volume standards for the biomass-based diesel fuel produced by XcelPlus Global, as well as for cellulosic and advanced biofuels. The combined volume requirements for 2010 are 12.95 billion gallons (bg), and, under the new regulations, continue to increase over the next 12 years, reaching 36 bg by 2022.

"This legislation sets the stage for us to enter some new, very large markets," said J. Michael Parsons, president and CEO of XcelPlus Global Holdings. "There is a synergistic effect as well, as this new legislation will also strengthen our strategic partners and stabilize our industry into the future." XcelPlus Global currently supplies biofuels made from plant oils, fats and other waste stream products to customers in asphalt/road construction, paper mills and lime kilns, among others.

"We are grateful for the efforts of Senator Maria Cantwell (D-WA) and for her understanding of the importance of making renewable fuels viable in the United States," said Parsons. Members of the XcelPlus Global management team will attend the National Biodiesel Conference in Dallas, TX next week to meet with EPA officials and explore opportunities presented with the new regulations.

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties, including, without limitation, the ability to obtain financing and regulatory and shareholder approval for anticipated actions.

FEATURED COMPANY

GREEN ENERGY LIVE INCORPORATED (OTCBB: GELV)

Detailed Quote: www.otcpicks.com/quotes/GELV.php

Company Profile: http://www.otcpicks.com/green-energy-live.htm

Green Energy Live Inc. is engaged in developing sustainable biomass-to-energy conversion technology to meet a critical need for the nation's $154 billion livestock industry. The company plans to use its proprietary gasification technology for the development of highly innovative, on-site manure-to-electricity conversion systems to enable livestock farmers and ranchers to convert their animal waste into clean, renewable energy.

GELV News:

February 4 - Green Energy Live Expands Operations to Accommodate Growth

Green Energy Live Inc. (OTCBB: GELV), a clean energy company engaged in developing sustainable biomass-to-energy conversion solutions for the U.S. livestock industry, is pleased to announce that the company has moved into new offices to accommodate its growing business. With its expanded team and new corporate headquarters Green Energy Live is focusing on the development of on-site manure to energy converters for farmers and ranchers, pursuing acquisitions of clean energy companies and technologies, and achieving sales and revenue increases through its wholly owned Comanche Livestock Exchange subsidiary.

Green Energy Live has moved out of a smaller executive office suite and into 2,500 square feet of newly leased office space in Wyoming, Michigan. The company is bringing together its executive, accounting and business development staff members to accommodate its plans for expansion.

The company has also added to its workforce. Green Energy Live has hired a seasoned Manager of Special Projects to identify green energy companies and technologies for potential acquisition, manage any upcoming acquisitions, align financial functions and reporting, provide support for Comanche's business, and manage marketing activities. A highly qualified in house accounting staff member has also been hired to support financial and reporting functions.

Comanche Livestock Exchange, a wholly owned subsidiary of Green Energy Live, generated an 18% increase in revenue and a 6% increase in net income in third quarter 2009. The company is a profitable livestock auction and hauling services provider with a 60 year operating history. Green Energy Live anticipates reporting on fourth quarter performance later this month.

Karen Clark, President/CEO of Green Energy Live, commented: "We are pleased to announce that we have officially outgrown our office space. With the expansion into new offices, addition of exceptional new team members and the identification of new opportunities to grow our business this is a very exciting time for Green Energy Live. We are balancing expansion activities with a keen eye on the bottom line, keeping overhead and expenses low while facilitating further growth."

FEATURED COMPANY

OPTIONS MEDIA GROUP HOLDINGS INCORPORATED (OTCBB: OPMG)

Detailed Quote: http://www.otcpicks.com/quotes/OPMG.php

Company Profile: http://www.otcpicks.com/options-media-group/options-media-group.htm

Options Media Group Holdings, Inc. is an email services provider for on-demand email marketing to create, send, and track professional and permission-based email marketing campaigns. Additionally, Options Media provides precision direct marketing solutions including email marketing, SMS/mobile marketing, SMS/keyword marketing, custom lead generation and creative services. Options Media provides clients with access to software, hardware, bandwidth, and exclusive domains and IP addresses, as well as the ability to upload and manage subscribers, and review and upload campaigns and track results for a 360-degree full-service customer marketing solution.

OPMG News:

February 4 - Emerging Growth Research, LLC Issues Research Briefing on Options Media Group Holdings, Inc.

Emerging Growth Research, LLC, a leading independent research and analysis firm, has issued a new research briefing on Options Media Group Holdings, Inc. (OTCBB: OPMG). The briefing examines the significant shift currently underway in the advertising industry, with investment dollars moving toward digital advertising media and away from more traditional outlets, including print, TV and radio, among others. Options Media Group is a leading direct digital marketing company with a strong management team, great client base and a comprehensive product and service offering for email and mobile marketing campaigns.

"With today's increasingly compressed product lifecycles, many advertisers prefer to utilize an outsourced technology platform solution rather than incurring both the time cost and investment expense necessary for the in-house development of a back-office system to support mobile advertising campaigns," commented Joe Noel, author of the briefing at Emerging Growth Research, LLC. "We believe this situation creates a compelling case for anticipated growth at companies that can provide such outsourced online and mobile messaging services. In this regard, one of our favorite companies in the digital advertising space is Options Media Group," concluded Noel.

The full report can be accessed at http://bit.ly/4QdwI2.

February 3 - Options Media Group Further Strengthens Balance Sheet

Options Media Group Holdings, Inc. (OTCBB: OPMG), a leading email service provider, permission based email, sms/text messaging marketing and mobile marketing company, announced today that holders of its remaining debt and key creditors have agreed to forgo cash payments for common stock of Options Media.

As of February 1, 2010, Options Media had no debt and over $1,000,000 in cash. The newly strengthened balance sheet will help Options Media move forward with its revised focus in the exciting and growing mobile marketing space.

"Options Media will focus its efforts in monetizing its recent acquisition of assets from WhatCounts Inc.," said Scott Frohman, Chief Executive Officer of Options Media Group. "We feel this acquisition will enable us to provide improved results for our customers. Additionally, our mobile marketing business will benefit from the overlapping synergies. I appreciate all the support from my former creditors and shareholders and look forward to building Options Media into a leader in the space."

FEATURED COMPANY

BIOMAGNETICS DIAGNOSTICS CORPORATION (OTC: BMGP)

Detailed Quote: http://www.otcpicks.com/quotes/BMGP.php

Company Profile: http://www.otcpicks.com/biomagnetics-diagnostics/biomagnetics-diagnostics.htm

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company's revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies.

BMGP News:

January 28 - Biomagnetics Diagnostics Initiating Clinical Trials for Integrated Optical Biosensor to Detect Malaria and Tuberculosis in Multiple Markets, Including Kenya, India and is in Talks to Initiate in Mexico

Biomagnetics Diagnostics Corp. (OTC: BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, announced that the Company is initiating several clinical trials in multiple markets, including Kenya and India, and is also in talks with one of the largest hospitals within the social security system of Mexico in order to address the clinical requirements of that market.

Through governmental agencies and blood banks in Kenya and India, Biomagnetics Diagnostics will have access to malaria (as well as other infectious diseases) infected blood that can be used to develop immunoassays and perform clinical trials on the Company’s integrated optical sensor in a cost effective, rapid manner.

At the end of last year, Biomagnetics Diagnostics contacted India’s Health Ministry Blood Bank in New Delhi, which specializes in malaria, with the goal of conducting clinical trials for product commercialization throughout India. In February the Company will meet with the Blood Bank as well as private institutions to initiate the administrative requirements to perform clinical trials. We will also start vetting potential distributors.

The Company is also in talks with Dr. Gustavo Barriga, Chief of the Laboratoria of the Hospital of Infectologia of the Centro Medico Nacional (CMN) La Raza, one of the largest hospitals operated under the social security system of Mexico, to discuss the Integrated Optical Biosensor (IBOS), clinical requirements and commercialization for the Mexican market.

We are very excited to begin clinical trials of the Company’s IOBS platform, commented Clayton Hardman, CEO of Biomagnetics Diagnostics. “We believe our integrated optical biosensor platform can significantly change the way point of care (POC) diagnostics are performed. These trials represent an important milestone for the Company and should create strong interest in our system.”

The Biomagnetics Diagnostics IOBS platform, which is made available in part via a technology transfer license from the Los Alamos National Security Laboratory, is a relatively new classification of pathogen detection equipment that uses advanced fiber optic-based technology to detect a wide variety of human and animal pathogens. These devices produced by the Company are specifically designed to be field deployable, ultraportable and very easy to use, allowing for extremely rapid detection of various viral and bacterial pathogens by relatively untrained personnel outside of the laboratory setting.

STOCKS TO WATCH

GEN2MEDIA CORPORATION (OTCBB: GTWO)
"Up 19.17% in morning trading"

Detailed Quote: www.otcpicks.com/quotes/GTWO.php

Gen2Media is a fully integrated technology, production and marketing company whose proprietary and patent-pending technology has earned the trust of a growing, globally diversified customer base, comprised of leading media companies, corporations, chart-topping artists, entertainment companies, advertising agencies and national brands such as The Black Eyed Peas, Mary J. Blige, Britney Spears, Justin Timberlake, Microsoft Xbox LIVE, Coca-Cola Company, Toyota, Clear Channel, and others.

GTWO News:

February 5 - SmallCapSentinel.com Announces the 'Future is Now' for Online Video

There are few who can predict the future with any accuracy. Fewer still profit from their hunches. But there are obvious trends that defy pessimism, that prove a path has been carved through an uncertain market and that the future is now for these new ideas. Given recent data, it's hard to argue that the future isn't at hand for online video.

This isn't a bold declaration. It's simply obvious amid the evidence. Look around. YouTube's a fixture on most American desktops and the breakout hit so far on American Idol wasn't realized on the show itself. Instead it was in the viral explosion of the "Pants on the Ground" video on YouTube.

Moreover, recent data from Comscore shows enormous viewership for online videos at Hulu.com and NetFlix which appears to be moving its business model to an online format instead of the old 'disk-in-the-mail' method.

For investors, this trend presents opportunity. Many foresaw the widespread adoption of MP3 music when Napster hit critical mass with college kids and then their parents. So, when Apple rolled out the iPod, they knew it was a game-changer, that the time had come for the presently ubiquitous super-device.

In online video, the aforementioned are certainly stocks to follow as the market grows beneath their corporate feet. But there are also niche companies to follow such as Gen2Media Corporation (OTCBB: GTWO), which has become a celebrity and top company choice to help them create the very videos eventually seen online. Gen2Media Corporation is a video technology company that provides the best-in-breed Online Video Platform, video production, and advertising on its Online Video Network that reaches over 10 million visitors monthly.

It's not Hulu's one billion videos a month but it's a big, big number for Gen2 which is effectively creating real credibility on both sides of the computer monitor.

POWER-ONE INCORPORATED (NASD: PWER)
"Up 16.13% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PWER.php

Power-One designs and manufactures energy-efficient power conversion and power management solutions for alternative/renewable energy, routers, data storage and servers, wireless communications, optical networking, semiconductor test equipment, industrial markets and custom applications. Power-One, with headquarters in Camarillo, California, has global sales offices, manufacturing, and R&D operations in Asia, Europe, and the Americas.

PWER News:

February 4 - Power-One Posts Solid Fourth Quarter 2009 Results

* Revenue increases to $142 million, up 42% sequentially
* Net income of $5.4 million and diluted EPS of $0.05
* Growth in renewable energy and power products, coupled with efficiencies and expense controls, drives operating cash flow to $28.1 million

Power-One, Inc. (Nasdaq: PWER), a leading provider of renewable energy and energy-efficient power conversion and power management solutions, today announced financial results for the fourth quarter 2009. The Company’s ongoing strategic initiatives, including growth strategies and a continued focus on efficiencies and expense controls, helped deliver expanded gross and operating margins, as well as positive operating cash flow and net income.

Power-One recorded net sales of $142 million for the fourth quarter ended January 3, 2010, an increase of 9% from the fourth quarter 2008. Net income attributable to common shareholders for the fourth quarter was $5.4 million, or $0.05 per diluted share, compared to a profit of $1.7 million, or $0.02 per diluted share for the same period last year.

Both renewable energy and power products recorded strong sequential revenue gains in the fourth quarter 2009, with a positive outlook for 2010. Renewable energy products posted another solid quarter, and the continued momentum from inverter products resulted in a record $68 million in revenue for the fourth quarter 2009. This yielded a year-over-year increase of 279% from $18 million in the fourth quarter 2008 and a 119% sequential sales increase from $31 million in the third quarter 2009. Renewable energy generated 48% of total revenue in the quarter, versus 14% in the fourth quarter of 2008. Power-One’s power products generated revenue of $74 million in the fourth quarter 2009, with these products showing continued signs of stabilization and modest demand increases.

Gross margin continued to expand for the third consecutive quarter, improving to 28.9% in the fourth quarter of 2009, compared with 22.0% for the same period last year. As part of Power-One’s strategic initiatives, a favorable product mix, better factory utilization and cost improvements all contributed to the expansion. Gross margin was negatively affected by $1.7 million in charges related to the closure of the Dominican Republic facility. Operating income for the fourth quarter 2009 was $13.2 million and was impacted by $4.1 million in total charges related to the closure of the Dominican Republic facility, slated to be completed by the first half of 2010.

Total 90-day backlog showed extraordinary growth, as Power-One posted $121 million in 90-day backlog. The renewable energy products 90-day backlog was $59 million, while the power products backlog grew to $62 million. This compares to backlog of $69 million in the fourth quarter of 2008, with renewable energy backlog of $6 million and power backlog of $63 million. The fourth quarter book-to-bill ratio was 1.88 compared to 0.80 in the fourth quarter of 2008. The book-to-bill ratio at the end of the fourth quarter for the renewable energy products was 2.22 and was 1.56 for the power products.

The cash balance at the end of the fourth quarter was $90 million, up from $76 million at the end of the third quarter of 2009. During 2009, cash flow from operations was $55 million, versus a use of $22 million in 2008. Due to better working capital management, inventory decreased 28% to $73 million versus $102 million at the end of the fourth quarter of 2008, while DSO dropped 23 days, ending the fourth quarter at 77 days versus 100 days in the fourth quarter of 2008.

“We are pleased with the progress we have made with our restructuring in power conversion and the rapid growth and outlook for our inverter sales,” commented Richard Thompson, Chief Executive Officer. “We have focused on improving our cost structure and strengthening power product sales and licensing, including our recent agreement with Ericsson. Further, we are investing in growth opportunities and new product initiatives, such as the launch of our 2.5 megawatt liquid-cooled wind inverter.”

“With the increasing demand for our renewable energy and power products, we look forward to a strong year in 2010. The successful implementation of cost controls and a focus on expanding our markets enabled us to generate greater cash flow on improving margins,” continued Mr. Thompson. “In the coming year, we will capitalize on cash flow generation and value to our shareholders through better manufacturing efficiencies, new product introductions and growth initiatives.”

Business Outlook

Consistent with prior quarters, the Company is not providing financial guidance.

Earnings Conference Call

Power-One will discuss its 2009 fourth quarter results today beginning at 2:00 p.m. Pacific Time. The call will be available over the Internet through the Company’s investor relations Web site at investor.power-one.com. To listen to the call, please go to the Web site at least 10 minutes early to register, download, and install any necessary audio software. For those who cannot listen to the live broadcast, the webcast will be available on the investor relations section of the Company’s Web site at investor.power-one.com throughout the current quarter.

SOMAXON PHARMACEUTICALS INCORPORATED (NASDAQ: SOMX)
"Up 6.18% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/SOMX.php

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. A New Drug Application (NDA) for Silenor® (doxepin), Somaxon’s drug candidate for insomnia, has been filed with the U.S. Food and Drug Administration and currently is under review.

SOMX News:

January 27 - Somaxon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference

Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) announced that Richard W. Pascoe, Somaxon’s president and chief executive officer, will present a company overview at the 12th Annual BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York City on Monday, February 8th at 9:30 A.M. Eastern Time.

A live webcast of the presentation will be available in the Investor Relations section of the company’s Web site (www.somaxon.com) under Event Scheduler. The webcast will be archived and accessible for at least 14 days.

ALKERMES INCORPORATED (NASDAQ: ALKS)
"Up 6.27% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ALKS.php

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.

ALKS News:

February 4 - Alkermes Reports Third Quarter Fiscal 2010 Financial Results

* Record Sales of RISPERDAL® CONSTA®
* Company Expands Proprietary Pipeline to Include Long-Acting Versions of Two Blockbuster Medications

Alkermes, Inc. (Nasdaq: ALKS) reported financial results for its third quarter of fiscal 2010, which ended on December 31, 2009.

Financial highlights:

* Quarterly revenues of $44.2 million, driven by record manufacturing and royalty revenues from RISPERDAL® CONSTA®. Worldwide sales of RISPERDAL CONSTA by Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Janssen-Cilag (Janssen) were approximately $399 million, growing 18.1% on an operational basis year-over-year. U.S. sales growth for the quarter ended December 31, 2009, was 13.7%, reflecting increased share and market growth while sales outside the U.S. were up 20.6% operationally.

* Net sales of VIVITROL® of $5.5 million, growing 17.4% over the prior quarter.

* GAAP net loss of $6.8 million and pro forma net income of $0.1 million.

* Strong financial position with cash and total investments of $357.5 million.

Other recent highlights:

* Alkermes announced a novel, proprietary LinkeRx™ technology platform that enables the creation of injectable extended-release versions of antipsychotics and other central nervous system (CNS) therapies. The company’s lead candidate that leverages this platform, designated as ALKS 9070, is a once-monthly, injectable, extended-release version of aripiprazole, commercially available under the name ABILIFY®, for the treatment of schizophrenia.

* Positive data reported for phase 3 study of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. XR-NTX, marketed by Alkermes as VIVITROL, is an opioid antagonist administered once-monthly by intramuscular injection and is approved in the U.S. and Russia for the treatment of alcohol dependence.

* Positive data reported for DURATION-5 head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.

* DURATION-6 clinical study initiated comparing exenatide once weekly to liraglutide, commercially available under the name VICTOZA®.

* Medifusion™ technology licensed from Acceleron Pharma, Inc. (Acceleron). The first drug candidate being developed with this technology, ALKS 6931, is a long-acting form of a TNF receptor-Fc fusion protein for the treatment of rheumatoid arthritis and related autoimmune diseases. ALKS 6931 is structurally similar to etanercept, commercially available under the name ENBREL®.

* Phase 2 clinical study initiated for ALKS 33, an oral opioid modulator for the potential treatment of addiction and other CNS disorders.

“The record RISPERDAL CONSTA sales in our third quarter underscore the increasing importance of this medication in the marketplace,” commented James Frates, Chief Financial Officer of Alkermes. “VIVITROL also had a strong quarter with double-digit growth. We will continue to focus on financial performance while leveraging our financial strength to invest in Alkermes’ proprietary pipeline and research and development efforts.”

Key operating results for the quarter ended December 31, 2009, include the following:

* GAAP net loss of $6.8 million or a basic and diluted loss per share of $0.07, including $3.4 million of share-based compensation expense and $3.6 million of charges associated with the relocation of the company’s headquarters. For the same period in 2008, GAAP net income was $112.7 million or a basic and diluted earnings per share of $1.18, including $120.6 million of one-time net income related to the company’s previous agreements with Cephalon, Inc. (Cephalon) for the commercialization of VIVITROL and $3.3 million of share-based compensation expense.

* Pro forma net income of $0.1 million or a basic and diluted earnings per share of $0.00, compared to a pro forma net loss of $4.6 million or a basic and diluted loss per share of $0.05 for the same period in 2008.

Revenues

* Total revenues for the quarter ended December 31, 2009, were $44.2 million, compared to $155.7 million for the same period in 2008 which included the recognition of $120.7 million of one-time revenue related to the company’s previous agreements with Cephalon.

* Manufacturing revenues for the quarter ended December 31, 2009, were $28.7 million, compared to $20.5 million for the same period in 2008. Manufacturing revenues for the quarter ended December 31, 2009, included $27.2 million related to RISPERDAL CONSTA and $1.5 million related to the manufacture of polymer for exenatide once weekly. In the quarter ended December 31, 2008, Alkermes recorded manufacturing revenue of $21.3 million for RISPERDAL CONSTA and reversed $0.8 million of manufacturing revenue related to VIVITROL, as a result of the termination of the collaborative agreements with Cephalon.

* Royalty revenues for the quarter ended December 31, 2009, were $10.0 million, based on RISPERDAL CONSTA sales of $398.7 million, compared to $8.0 million, based on RISPERDAL CONSTA sales of $318.8 million for the same period in 2008.

* Net sales of VIVITROL recorded by Alkermes for the quarter ended December 31, 2009, were $5.5 million, growing 17.4% over the prior quarter.

* Research and development (R&D) revenue under collaborative arrangements for the quarter ended December 31, 2009, was $0.1 million, compared to $3.7 million for the same period in 2008.

* Net collaborative profit for the quarter ended December 31, 2009, was $0. Net collaborative profit for the quarter ended December 31, 2008, was $123.4 million and included the recognition of $120.7 million of one-time milestone and deferred revenue related to the company’s previous agreements with Cephalon and $1.2 million of deferred revenue prepaid by Cephalon to cover its share of VIVITROL losses.

Costs and Expenses

* Cost of goods manufactured and sold for the quarter ended December 31, 2009, was $10.1 million, of which $8.4 million related to RISPERDAL CONSTA, $1.1 million related to VIVITROL and $0.6 million related to the manufacture of polymer for exenatide once weekly. This compared to $5.5 million for the same period in 2008, of which $5.0 million related to RISPERDAL CONSTA and $0.5 million related to VIVITROL.

* R&D expenses for the quarter ended December 31, 2009, were $22.6 million, compared to $22.7 million for the same period in 2008.

* Selling, general and administrative (SG&A) expenses for the quarter ended December 31, 2009, were $17.7 million, compared to $14.6 million for the same period in 2008.

* Share-based compensation expense (included in the expenses above) for the quarter ended December 31, 2009, was $3.4 million, of which $0.4 million related to cost of goods manufactured and sold, $0.8 million related to R&D expenses and $2.2 million related to SG&A expenses. Share-based compensation expense for the same period in 2008 was $3.3 million, of which $0.3 million related to cost of goods manufactured and sold, $0.5 million related to R&D expenses and $2.5 million related to SG&A expenses.

* Interest income for the quarter ended December 31, 2009, was $1.0 million, compared to $2.6 million for the same period in 2008. Interest expense for the quarter ended December 31, 2009, was $1.4 million, compared to $2.4 million for the same period in 2008.

At December 31, 2009, Alkermes had cash and total investments of $357.5 million, compared to $369.5 million at September 30, 2009. During the quarter, the company used $10 million to license the Medifusion technology platform from Acceleron, including a $2 million upfront payment and an $8 million equity investment in Acceleron. The company also retired $6.4 million of the non-recourse RISPERDAL CONSTA secured 7% Notes through a scheduled principal payment.

ALKANE INCORPORATED (OTC: ALKN)
"Up 12.28% in morning trading"

Company Profile: http://www.otcpicks.com/alkane-inc.htm

Alkane, Inc. is dedicated to the development and sales of alternative fuels and additives which reduce the cost of operating and maintaining vehicles. Additional benefits of Alkane, Inc.'s product offerings include positive environmental impact through the reduction of harmful emissions and a lessened U.S. dependence on foreign oil due to a decrease in crude oil dependent diesel fuel consumption.

ALKN News:

February 2 - Alkane's Monster Diesel Packs in Energy and Creates Positive Environmental Impact

Paul Sr. of Orange County Choppers™ Speaks from First Hand Experience

Alkane, Inc.’s (OTC: ALKN) flagship product, Monster Diesel™, was featured in the January 28 episode of TLC’s American Chopper™, which will re-air Thursday, February 4, on TLC at 8pm ET/PT.

Paul Teutul Sr., Founder of Orange County Choppers™ (around which the show is filmed) spoke from the first hand experience he acquired while converting a three cylinder tractor motor into a street legal motorcycle engine for a custom built, first of its kind diesel powered chopper for Monster Diesel™. “You could really feel the difference when you put in the Monster Diesel additive,” Teutul said. “The black smoke is gone and you could absolutely feel the power.”

“The boost in power to which Paul Sr. is referring comes from the patent pending synthetic molecule contained in Monster Diesel,” said Mathew Zuckerman, Ph.D., CEO & President of the company. “Many diesel users think of white smoke as a danger signal. But what we have is essentially a reduction in soot, making the exhaust much lighter in color. This burning of the soot is a good thing. We are actually trapping the soot particulates and burning them for more energy. In effect, this gives the user better mileage per gallon and makes for cleaner emissions.”

Teutul's endorsement carried weight with consumers. The company has seen dramatic interest since the show's airing. Call and email volumes have soared, according to Lou Petrucci, Vice President of Sales & Marketing. “The interest we have seen since the airing of just one episode is astronomical. The number of sales and inquiries we have received indicates there is an enormous market for this product.” Petrucci says Monster Diesel™ is actively pursuing other avenues to get the product in front of consumers and points to the stellar response as an indication of the extensive opportunities for growth. Petrucci went on to say, “We are executing a very aggressive strategy. And this really affirms that our strategy is effective.”

ABOUT MONSTER DIESEL™

Monster Diesel™ is a patent pending high energy “green” alternative fuel additive which boosts diesel fuel’s quality to premium levels and is designed for use in any diesel powered motor. The additive offers a comprehensive, cost effective solution to address each of the challenges common to diesel powered engines, all in one product. Benefits of Monster DieselTM include:

* Reduces diesel consumption by as much as 15%.
* Boosts diesel fuel’s energy by 10% for increased power and mileage per gallon.
* Reduces metal to metal engine wear and friction by as much as 40%, to reduce down time.
* Lowers overall fuel emissions by 23%.
* Turns black smoke to white instantly, harnessing would-be pollutants into increased power and mileage per gallon.
* Winterizes diesel fuel to allow subzero operation, eliminating the need for expensive #1 diesel to reduce gelling and icing.
* Boosts the cetane number by 12.5%—twice the boost of premium gas over regular.
* Made from U.S. sourced materials, not crude oil.

VIRTUALSCOPICS INCORPORATED (NASDAQ: VSCP)
"Up 13.21% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/VSCP.php

VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster.

VSCP News:

February 4 - VirtualScopics' Project Balance Hits New Record Level

71% increase over prior year

VirtualScopics, Inc. (Nasdaq: VSCP), a leading provider of quantitative imaging for clinical trials, today announced that its project balance exceeds $41 million compared to $24 million at the same time a year ago, representing a greater than 70% increase. The company defines project balance as the amount remaining to be earned from active projects and awards, and commonly referred to as backlog within the industry. The average duration of the projects included within the backlog is approximately forty-five months and the company anticipates that awarded contracts will be signed within the next several months as the projects near their start dates.

Vice President of Business Development, Rosemary Shull stated, "These results are not only a great reflection of the strength of our business development efforts in 2009, but of the confidence our customers have in our operational performance and ability to deliver high quality results on a consistent basis." She added, "The continued growth of our backlog, which has risen from $15 million just two years ago, has been driven by both new business efforts and a greater penetration within existing customers." Ms. Shull concluded," We are looking forward to another solid year in 2010."